#Joseph J. Rotman

[yourfaveisstudyingtopology]

Lain Iwakura from Serial Experiments Lain is reading An Introduction to Algebraic Topology by Joseph J. Rotman.

[isomorphismes]

Revolutionary events were changing Europe in the early 1500’s: the printing press; Asian trade; American exploration; the Reformation. The Italian peninsula was not one country but a collection of city-states with many wealthy and cosmopolitan traders. Modern algebraic notation did not exist at this time. Designating variables by letters was invented by Viète in 1591. (He used consonants for constants and vowels for variables.) Writing superscript for repeated multiplication is due to James Hume—in 1636 he used Aⅱ, Aⅲ, Aⅳ, …. Even +, –, and √ were new, having been introduced in 1486 by Johannes Widman. × was introduced by William Oughtred in 1631 and ÷ by Johann Rann in 1659. Our «equals symbol» = was introduced by Robert Recorde in 1557, in his Whetstone of Witte: And to avoide the tediouse repetition of these woordes: is equal to: I will lette as I doe often in woorke use, a paire of paralleles, or gemowe lines of one lengthe, thus: ═, because noe 2 thynges, can be moare equalle. (gemowe is an obsolete word meaning twin or, in this case, parallel.)

Joseph J Rotman (1995)

citing Robert Recorde (1557), Johann Rann (1659), William Oughtred (1631), Johannes Widman (1486), James Hume (1636), and François Viète (1591)

#gemowe #= #Robert Recorde #Whetstone of Witte #Oxford #Cambridge #René Descartes #François Viète #Johann Rann #Johannes Widman #isomorphic #William Oughtred #slide rule #same #alike #Whetstone of Wit #equals #equal #algebra #history #equality #history of ideas #Joseph J. Rotman #to equivalence class #constants #variables #equivalence #isomorphism #consonants #vowels

[pythagoriantymek]

A First Course In Abstract Algebra

A First Course In Abstract Algebra

John B Fraleigh 

A First Course in Abstract Algebra, 7th Edition - AbeBooks Nov 6, 2002. Considered a classic by many, A First Course in Abstract Algebra is an in-depth introduction to abstract algebra. Focused on groups, rings and A First Course in Abstract Algebra 3rd Edition: Joseph J. Rotman book - Abstract Algebra: Theory and Applications - University of. A First Course in Abstract Algebra. by John B. Fraleigh - JStor Buy A First Course in Abstract Algebra Featured Titles for Abstract Algebra by John B. Fraleigh ISBN: 9780201763904 from Amazon's Book Store. Free UK Special Notation - Mathematics - University of Illinois at Urbana. Review: A First Course in Abstract Algebra. User Review - Marius - Goodreads. Extremely well-written. I used it for my first course in algebra and also as a cross Abstract Algebra - How to Become a Pure Mathematician or. Aug 10, 2011. Chapters 1 through 6, 9, 10, 11, 13 the first part, 16, 17, 18 the first most students taking a course in abstract algebra have been introduced Pearson - First Course in Abstract Algebra, A, 7/E - John B. Fraleigh material in the first half of the text in order to cope with the higher level of. trimester course in abstract algebra for regular as opposed to honors majors. Sep 1, 2014. Of course, it is hopeless Dependence Chart 0-11 j: 13-15 16 34 ~ I I is a one-to A first course in abstract algebra jb fraleigh, 7 ed2003.djvu. A First Course in Abstract Algebra Featured Titles for Abstract. Solutions to. A First Course in. Abstract Algebra. John B. Fraleigh sixth edition. ISBN 0-201-33596-4. Addison Wesley Longman by. Ben Hekster. PO Box 391852. Generic Error - eFollett Find great deals on eBay for A First Course in Abstract Algebra in Education Textbooks. Shop with confidence. A First Graduate Course in Abstract Algebra - CRC Press Book Considered a classic by many, A First Course in Abstract Algebra, Seventh Edition is an in-depth introduction to abstract algebra. Focused on groups, rings and at the start of an abstract algebra course may destroy interest in the subject. Accordingly text that gave axioms for a vector space in the ?rst chapter and then. A first course in abstract algebra - John B. Fraleigh, Victor J. Katz Access A First Course in Abstract Algebra 7th Edition solutions now. Our solutions are written by Chegg experts so you can be assured of the highest quality! Nov 6, 2002. Available in: Paperback,Hardcover. Considered a classic by many, A First Course in Abstract Algebra, Seventh Edition is an in-depth. A First Course in Abstract Algebra, 7th Edition: John B. Fraleigh Noté 4.5/5. Retrouvez A First Course in Abstract Algebra et des millions de livres en stock sur Amazon.fr. Achetez neuf ou d'occasion. Abstract Algebra - Ben Hekster This book deals with several topics, which introductory abstract algebra texts. Anderson M. and Feil T. A First Course in Abstract Algebra: Rings, Groups, and ?A First Course in Abstract Algebra 7th Edition English 7th. - Flipkart A First Course in Abstract Algebra 7th Edition English 7th Edition - Buy A First Course in Abstract Algebra 7th Edition English 7th Edition by John B. Fraleigh A First Course In Abstract Algebra 7th Edition Textbook Solutions. A First Course in Abstract Algebra 3rd Edition Joseph J. Rotman on Amazon.com. *FREE* shipping on qualifying offers. This text introduces readers to the A First Course in Abstract Algebra / Edition 7 by John B. Fraleigh regulation 8 exam guide of customs solution manual of first course on power. 2011 victory service manual a first course in abstract algebra solutions pdf -. A First Course in Abstract Algebra - John B. Fraleigh - Google Books Nov 1, 2002. A First Course in Abstract Algebra has 137 ratings and 8 reviews. Marius said: Extremely well-written. I used it for my first course in algebra and A FIRST COURSE IN ABSTRACT ALGEBRA - Department of. ?Sep 14, 2015 - 26 sec - Uploaded by Michael MartinA First Course in Abstract Algebra, 7th By John B. Fraleigh International Economy Edition PDF In previous courses you have seen many kinds of algebra, from the algebra of. for this course is John B. Fraleigh, A first course in abstract algebra, 7th edition, kpgillespie - A First Course In Abstract Algebra-Jb Fraleigh, 7Ed. Considered a classic by many, A First Course in Abstract Algebra, Seventh Edition is an in-depth introduction to abstract algebra. Focused on groups, rings and A First Course in Abstract Algebra by John B. Fraleigh — Reviews Taking a classical approach to abstract algebra while integrating current applications of the subject, the new edition of this bestselling algebra text remains . Amazon.fr - A First Course in Abstract Algebra - John B. Fraleigh A FIRST COURSE. IN ABSTRACT ALGEBRA. Third Edition. JOSEPH J. ROTMAN. University of Illinois at Urbana-Champaign. PRENTICE HALL, Upper Saddle Solution Manual For First Course Abstract Algebra Textbooks & Course Materials · Digital Course Materials · Cash for Books. Online Adoptions · Univ Custom Pub · LAD Custom Pub · XanEdu: Course Packs. A First Course in Abstract Algebra: John B. Fraleigh: 9781292024967 Aug 24, 2015. A First Course In Abstract Algebra-Jb Fraleigh, 7Ed2003.pdf · Download 0 1 0 Tags. No tags. Notify · RSS · Backlinks Math 113: Abstract algebra A First Course In Abstract Algebra-Jb Fraleigh, 7Ed2003.djvu Considered a classic by many, A First Course in Abstract Algebra is an in-depth introduction to abstract algebra. Focused on groups, rings and fields, this text A First Course in Abstract Algebra - John B. Fraleigh - Google Books MATH-4010 Abstract Algebra A First Graduate Course in Abstract Algebra is just such a textbook. Divided into two sections, this book covers both the standard topics groups, modules, rings, A first course in abstract algebra jb fraleigh, 7 ed2003.djvu AbeBooks.com: A First Course in Abstract Algebra, 7th Edition 9780201763904 by Fraleigh, John B. and a great selection of similar New, Used and Collectible Download A First Course in Abstract Algebra, 7th By John B. Course material at Rensselaer Polytechnic Institute, Troy, NY Last update: May 14, 2015. Text, A First Course in Abstract Algebra 7th edition by John B.

#I did my best #Especially with the French #I'm sorry to the French language #I did a thing! #My art

[sixpenceee]

This book is Joseph J. Rotman, An Introduction to Algebraic Topology.

#posts #sixpenceee

[booksarefuckingdrugs]

35 Writers Who Took Book Dedications To Another Level - part.1

Graduate Texts In Mathematics - An Introduction To Algebraic Topology by Joseph J. Rotman

To my wife Marganit

and my children Ella Rose and Daniel Adam

without whom this book would have been completed two years earlier

Unknown

For everyone with a red line

under their name in Microsoft Word.

Mortal Coil by Derek Landy

Unknown

For Carley, who was a better person than I am

even though she was a dog

Diary Of A Mad Diva by Joan Rivers

This book be dedicated to Kanye West,

because he'll never fucking read it.

Death Bringer by Derek Landy

Unknown

For my wife,

who somehow managed to be

nothing but supportive of a book about

all the women I slept with before I met her.

No Way Back by Mathhew Klein

For Mom

(Just skip over the sex scenes, please)

The Selection by Kiera Cass

Hi, Dad!

*waves*

The End Games by T. Micheal Martin

Everything not saved will be lost.

-Nintendo "Quit Screen" message

[mongoose232323]

To My Wife Marganit And My Children

~ Joseph J. Rotman ~

👍😁

[sageseulgilee-blog]

Week 6 : Activism and protest.

In the previous week, we have covered ‘digital citizenship’ which has slightly different definition to the original meaning of ‘citizenship’. As there have been ‘activists’ in our history whose contributed changes to the world, there are also ‘activists’ in the digital society. Similar to the society, these activism and protests sometimes involved with politics, or purely generated by people who are interested. We can find there are more various and audacious campaigns are introduced due to the anonymity of the internet.

Culture jamming concept was firstly found in the mid 1980’s and then developed by Mark Dery. He claimed culture jamming as ‘ads, newscasts, and other media artifacts with subversive meanings; simultaneously, they decrypt them, rendering their seductions impotent (Day pp.504).’ Billboard banditry, subvertising and media hoaxing are some examples of culture jamming. Adbusting, same as subvertising, is one of the form of culture jamming. Difference between propaganda graffiti and this is that culture jamming and subvertising usually illustrate radical and liberal points (Anderson & Herr 2007 pp.636).

With the development of media technology, culture jamming also has been changed to a new form ‘Meme’ in the social media world. News spread online, and people read the news and create new memes with their own opinions and share the meme fast.

From my point of view, all these changes will bring a positive change. Kony2012 is a campaign that shows how today’s small activist campaign can turn into a massive campaign regardless of its outcome. Even though the campaign did not achieve the initial aim of capturing Joseph Kony, the campaign itself is recognised as a successful campaign based on results: for instance, in 2017, they Kony2012 spent donated US 1.7 million for their program (Kony2012), and the amount of donation is considered to be quite large as the campaign is online based, also not running by a famous organisation like red cross. On the other hand, some argue that the campaign is not quite successful campaign and I would like to find reasons from these facts: the campaign is considered using slacktivism meaning ‘low‐risk, low‐cost activity via social media, whose purpose is to raise awareness, produce change, or grant satisfaction to the person engaged in the activity’ (Rotman et al 2011 pp.280). Slacktivism is usually not not successful is because users usually do not have enough power to affect decision makers (Chazal, Pocrnic 2016 pp.105). Despite of these, I still value how one small online campaign attracted viewers and made them to become digital citizens whose actually participate to try to make changes.

Reference

Anderson & Herr 2007 Title: Encyclopedia of Activism and Social Justice Sage publications Thousand oaks

Chazal N, Pocrnic A 2016 Kony2012:Intervention Narratives and the Saviour Subject International Journal for Crime, Justice and Social Democracy, 01 March, Vol.5(1), pp.98-112

Day A, 2016 Culture Jamming and Media Activism A Companion to Popular Culture John Wiley & Sons, Ltd

Kony2012, 2019 Financials, viewed 1 Feb 2019 <https://invisiblechildren.com/financials/>

Rotman D, Preece J, Vieweg S, Ben S, Yardi S, Pirolli P, Chi EH and Glaisyer T, 2011, From slacktivism to activism: Participatory culture in the age of social media CHI '11 Extended Abstracts on human factors in computing systems 07 May 2011, pp.819-822

[otcsocialnetwork]

$VYST 5 Significant Key Points to Summarize NASDAQ Objectives 

VYST 5 Significant Key Points to Summarize NASDAQ Objectives Huge VYST News*250 Million Share Buyback/Pays Off Debt https://investorshub.advfn.com/boards/read_msg.aspx?message_id=146108243 https://investorshub.advfn.com/boards/read_msg.aspx?message_id=146049818 Key Point #1**No Reverse Split I reached out to the company and confirmed that there is no reverse split. I was informed by the company that the only way that VYST would do a reverse split would be if they needed to do a small one to meet NASDAQ requirements which was why such was given an honorable mention within their last 10-Q: https://www.otcmarkets.com/filing/html?id=13070644&guid=kjy8UWUD04sjm3h I was also informed that if such is the case, VYST would announce a no higher than a 1-10 reverse split at the same time of announcing their application submission to trade on the NASDAQ. If such was to happen, it would be after their upcoming closing of their acquisition of Rotmans that was listed within their last 10-Q under Note 12 Subsequent Events which would immediately make them a NASDAQcompany because of the Revenues and Profits that they are generating: https://www.otcmarkets.com/filing/html?id=13070644&guid=kjy8UWUD04sjm3h The company totally understands that a reverse split is not good for the market and would never do such unless VYST needed to meet the NASDAQ requirement of having a minimum $4.00 Bid. Based on the logic from my conversation and the ratio of no higher than a 1-10, they plan to see VYST trading at .50+ per share before such is needed to graduate the company to the NASDAQ or a reverse split would never happen. The company also told me that there will be a share buyback in the near future. To reiterate… The company informed me that they are going to qualify for NASDAQ with their Revenue and that if they ever did a reverse split, they would be filing for the NASDAQ and a small 1-10 reverse split on the same day. v/r Sterling https://investorshub.advfn.com/boards/read_msg.aspx?message_id=146050256 Key Point #2**The Immediate .67+ & .26+ Valuations I have seen where some had posted where Rotmans generates between $50 to $100 Million in Revenues. I was told by the company that such was not true. The company told me that Rotmans generates over $35+ million in Revenues with a 48% to 52% Gross Profit Marginand a 19% Net Profit Margin. The company informed me that all the conversions have been completed and that the Outstanding Shares (OS) should be somewhere below 500 million shares. From my conversation, the company believes that the Price to Earnings (PE) Ratiois higher than 20 for its growth rate, but I will use 20 to remain conservative. From these variables, we can derive the Fundamental Valuation as indicated below from two different models: Gross Profit Margin Model and the Net Profit Margin Model: Gross Profit Margin Model The company informed me that from their over $35 million in Revenues, they have a 48% to 52% Gross Profit Margin. I will use the 48% to remain conservative. Consider below to derive an Earnings Per Share (EPS): $35,000,000 Revenues x .48 Net Profit Margin = $16,800,000 Net Income $16,800,000 Gross Income ÷ 500,000,000 (OS) = .0336 EPS .0336 EPS x 20 PE Ratio = .672 Per Share Gross Value Net Profit Margin Model The company informed me that from their over $35 million in Revenues, they have a 19% Net Profit Margin. Consider below to derive an Earnings Per Share (EPS): $35,000,000 Revenues x .19 Net Profit Margin = $6,650,000 Net Income $6,650,000 Net Income ÷ 500,000,000 (OS) = .0133 EPS .0133 EPS x 20 PE Ratio = .266 Per Share Net Value The company told me that FINRA will likely have them roll Rotmans’ financials up into VYST as the financials for moving forward because of how huge the acquisition would be for the VYST. v/r Sterling https://investorshub.advfn.com/boards/read_msg.aspx?message_id=146062058 Key Point #3**VYST $1.5M Debt Paid & Acquisition Payment This is huge in my opinion and shows that the company is serious about moving forward with their goals. Also, important to note, I was informed that the Rotmans Furniture store acquisition price is $4 million that will be bought with cash and stock that only converts post reverse split price. The stock component just can’t convert unless it’s post-reverse. This means that the acquisition will be a lot less dilutive. They wanted to be overly fair, especially since the Insiders own over 75% of the Outstanding Shares (OS). Within the PR below, pay close attention to where it says… CMA Investments, LLC and its guarantors accepted 15M shares of restrictedVystar common stock as payment for the principal and interest on the decade-old loan. This is a huge show of confidence that leads me to think that they believe that such 15 Million shares are considered at a discount to where they still would make money off of their shares for knowing what is coming. Think about it… $1,500,000 Debt ÷ 15,000,000 Restricted Shares = .10 Per Share This means that they were willing to accept 15,000,000 of VYST Restricted Shares at .10 per share to pay off $1.5 Million in Debt. Maybe it’s me, but this leads me to believe that whatever they learned to accept such a payoff in VYST Restricted Shares, is going to take the price far higher than .10 per share. Read the PR below: Quote: https://seekingalpha.com/news/3370252-vystar-pays-long-term-debt-1_5m Vystar pays off long-term debt of $1.5M Jul. 16, 2018 9:02 AM ET|About: Vystar Corp. (VYST)|By: Niloofer Shaikh, SA News Editor Vystar Corporation (OTCPK:VYST) has paid off $1.5 M in long-term debt, for a total reduction in long-term debt of $2.6M this year. CMA Investments, LLC and its guarantors accepted 15M shares of restricted Vystar common stock as payment for the principal and interest on the decade-old loan. Stated Steve Rotman, CEO of Vystar, “Vystar is now totally free of long-term debt and liens. This helps clean up our balance sheet and enables a fresh start as we execute our strategic plan that includes further acquisitions, expanding the Vytex distribution network, development of new Vytex formulations, and development and launch of new product lines.” v/r Sterling https://investorshub.advfn.com/boards/read_msg.aspx?message_id=146094320 Key Point #4**VYST Key Ownership Confirmation via Form 4s After speaking to the company, I learned that Insiders own over 75% of the company. I was told that in the ten years since the Inside ownership has been owning their shares, there has been not one sell. I was told that this can be confirmed via the hundreds of Form 4s filed with the SEC as some of them are very prominent people of which are on the Board for the company. I counted over 280 ownership forms filed, but I won’t go through them all as I will try to only highlight a few key prominent VYST personnel and Board Members. Even though some might not be Board Members anymore, they still are shareholders and provide major input for their investment into VYST and still have a vested interest in their success: (Sort by the “100 Entries” tab) https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001308027&type=&dateb=&owner=only&start=100&count=100 Quote: Doug Craft CEO of and owns Medicraft, Inc. who is the largest supplier to Medtronic in the world. Medtronic is a $113.9 Billion company that trades on the NYSE at $84.00+ per share: https://finance.yahoo.com/quote/MDT/key-statistics?p=MDT https://www.medtronic.com/us-en/index.html http://www.medicraft.com/ Mitsy Y. Mangum Owns Lakeview Capital Partners LLC which an over $3 billion in assets under management and she is also a Managing Director: https://www.bloomberg.com/profiles/people/16697549-mitsy-y-mangum https://www.bloomberg.com/profiles/companies/1299368D:US-lakeview-capital-partners-llc This link shows that Lakeview Capital Partners has $2.6 Billion in Assets: https://money.usnews.com/financial-advisors/firm/lakeview-capital-partners-llc-165931 Michael Ianacone ** Previously the old VP of Xerox Global and has his own value company now. Quote: https://filexch.host/?q=Mike+ianacone+xerox+drivers Joseph C. Allegra ** Owns Lincoln Lee Investment, Zurich Investment (a $25 Billion Hedge Fund), Diamond Investments I and II, Italian Air I and II. ** He owns the patent on the titanium surgical screw that many people use in many surgeries. ** On the Board Of Directors for MET-test: https://www.mymettest.com/ Quote: http://www.mettest.net/about_us.html Since inception in 2003, MET-TEST has been providing pulmonary function testing (PFT) and cardiopulmonary exercise testing (CPET) as a standard and centralized service to community based clinics. We have performed well over 65,000 tests and studies in the last 7 years and in the process have accumulated study results and expertise that we routinely share with partners. We work very closely with Dr. Wasserman at Harbor-UCLA, which is nationally recognized as the number one exercise physiology lab in the world. We currently provide services to 53 clinics in nine states as well as participating in Clinical Trials with a Pharma partner. Our expansion plans not only include additional sites in the United States but International as well. We are a privately held corporation headquartered in Atlanta, Georgia. Quote: http://www.mettest.net/board_of_diretors.html Quote: J C Allegra, MD Age 62 Atlanta Georgia Married ( Marilyn ) 3 children / BA from Temple University ( Chemistry ) 1970 / MD from Penn State University//Hershey Medical Center 1974 / Internship and Residency Internal Medicine 1974-1976 Hershey Medical Center / Fellowship Medical Oncology NIH/NCI Bethesda MD 1976-1978 /Senior Investigator NIH/NCI 1978-1980 /Military USPHS 1976-1980 Lt Cmdr / Professor and Chairman of Department of Medicine at University of Louisville 1982-1989 / Ended academic career in 1989 and moved to Atlanta Georgia to become President of T-2 Medical a physician centric Home Health Company Responsible for revenue growth between 1989 and 1993 from 50M to 300M and for listing T-2 on NYSE. Post T-2 functioned as President of OTI a Division of PhyMatrix which was a physician management company in Florida. Left PhyMatrix in 1997 to form NMCR a physician oriented education company and from 1997–2006 led the growth of NMCR to the largest oncology oriented education company in the USA prior to its purchase by Amerisource Bergen. Since 2006, I have functioned as the owner of Lincoln Lee Investments, LLC a family owned investment organization oriented to Health Care Investments Serve on numerous Public and Private Boardsand am the author of over 100 publications in peer reviewed medical publication. Dr. Keith D. Osborn ** Keith is a surgeon by trade, but has vast real estate holdings who is also a big investor with Joe Allegra, the other VYST Board Member. https://www.resurgens.com/physicians/keith-d-osborn-md Quote: https://www.bloomberg.com/research/stocks/people/person.asp?personId=183937861&privcapId=12739579 Mr. Keith D. Osborn, M.D., serves as Orthopedic Spine Surgeon at Resurgens Orthopaedics, Atlanta, GA. Mr. Osborn serves as a Member of Technical Advisory Board at Vystar Corporation. He has been Director of Vystar Corporation since May 18, 2016. He is a board-certified Orthopaedic Spine Surgeon with 30 years of experience after completing his Spine Fellowship at Harvard University. He received his medical degree from the University of Maryland School of Medicine and performed his residency at Harvard University and Johns Hopkins Hospital. Dr. Osborn currently specializes in Spinal Surgery at Resurgens Orthopaedics in Atlanta with a focus on adult spinal disorders and total disc arthroplasty. Paul R. Oristaglio Quote: https://www.bloomberg.com/research/stocks/people/person.asp?personId=571959708&privcapId=12739579 Mr. Paul R. Oristaglio, CPA has been a Director of Vystar Corp. since June 20, 2018. Mr. Oristaglio is the Chief Executive Officer and Founder of CFO2higher, which provides financial solutions to business owners and managers, which Mr. Oristaglio started in May 2018. Prior to his position with CFO2higher, Mr. Oristaglio served as President and Sole Proprietor of RIPRO, a financial and operational services company, and prior to that, MR. Oristaglio was CFO, COO, CIO and Co-Founder of MassPRO, Inc., a financial/operation resources company. Mr. Oristaglio is a licensed CPA. Mr. Oristaglio was chosen to serve as a director due to his business acumen and financial background. https://www.cfo2higher.com/ Steven Rotman Vystar Names Furniture Industry Leader Steve Rotman as CEO; Appoints 3 Board Members Quote: https://www.cnbc.com/2017/12/20/globe-newswire-vystar-names-furniture-industry-leader-steve-rotman-as-ceo-appoints-3-board-members.html Mr. Rotman brings extensive management experience to Vystar. He has been President and CEO of Rotmans, one of the oldest and largest furniture and carpet retailers in New England, for more than 40 years. … “I’m looking forward to working with the Vystar team and its partners in this new role to unleash Vystar’s sales and profitability potential,” stated Steve Rotman. “Vystar’s management, largest creditors, partners, NHS Holdings and major shareholders have worked together over the past six months to formulate a three-pronged strategic plan that would create a sustainable model to bring greater value to all Vystar shareholders. The three strategies are 1) revise Vystar’s business model to enhance revenues beyond Vytex as a pure commodity, 2) augment product offerings, profit margins, and revenues through acquisition, and 3) add depth to senior management.” Lam Ngoc Minh Quote: https://globenewswire.com/news-release/2017/06/01/1005429/0/en/Major-Latex-Foam-Producer-Lien-A-Partners-with-Vystar-CEO-Invests-in-Vystar.html VYST has formed a strategic partnership with Lien ‘A, pairing Vystar’s multi-patented, all-natural, virtually allergen free Vytex® latex with one of the top eco-friendly latex foam producers in Vietnam who provides natural rubber latex (NRL) products to 31 countries worldwide. Over the past year, Lien ‘A’s CEO Lam Ngoc Minh took significant equity positions in Vystar and NHS Holdings, LLC (NHS)… Minh joins a core group of Vystar investors who have invested $20 million in Vystar since inception to launch Vytex in multiple vertical markets and spur the latex and plastics industries to change to sustainably sourced, more durable and biodegradable materials. Dr. Bryan L. Stone Quote: https://www.bloomberg.com/research/stocks/people/person.asp?personId=547878243&privcapId=12739579 Dr. Bryan Lawrence Stone , M.D. serves as Interim CEO of Fluid Energy Conversion, Inc. Dr. Stone is the Chairman of Medicine at Desert Regional Medical Center in Palm Springs, Calif., and is the Medical Director at multiple DaVita Dialysis Centers. He is also an entrepreneur. He has advised Vystar over the past years relating to product development for the healthcare industry and brings to the board an understanding of the challenges of new product development for start-up companies. He has been Director of Vystar Corporation since December 20, 2017. William R. Doyle Quote: https://www.bloomberg.com/research/stocks/people/person.asp?personId=49551313&privcapId=12739579 Mr. William R. Doyle, also known as Bill, has been Product Development Consultant at Vystar Corporation since December 20, 2017. Mr. Doyle served as Chief Executive Officer of Vystar Corporation since March 2008 until December 20, 2017 and served as its President since December 2005 and served as its Chief Financial Officer since May 1, 2015. Mr. Doyle served as the Interim Chief Financial Officer of Vystar Corporation from July 29, 2014 to February 1, 2015 and served as its Chief Operating Officer since December 2005. Mr. Doyle served as Vice President of Marketing at Women’s Health for Matria Healthcare, Inc. He spearheaded the initial branding efforts at Matria as well as held responsibility for sales development, training, public relations and marketing. He has worked in many aspects of healthcare industry for over twenty years encompassing manufacturing, sales, marketing and advertising. In addition to Matria, he has experience with such companies as Isolyser Company, Inc., McGaw, Inc., Wyeth (Formerly, Lederle Laboratories), and in an advertising capacity for Novartis Ophthalmics. He served as Chairman of the Board at Vystar Corporation since March 2008 until December 20, 2017. He served as a Director of Vystar Corporation since 2005 until December 20, 2017. He serves as a Member of the Board of Directors of the Georgia Chapter of the March of Dimes. Mr. Doyle holds a Bachelor of Science in Biochemistry from Penn State University and Master of Business Administration from Pepperdine University. Ranjit K Mattha Quote: https://www.bloomberg.com/research/stocks/people/person.asp?personId=288343347&privcapId=12739579 Dr. Ranjit K. Matthan, Ph.D. serves as Director of R&D at Vystar Corporation. Dr. Matthan served as a Consultant to Vystar since 2008. Dr. Matthan has played a significant role in the manufacturing scale up of reduced-protein Vytex® natural rubber latex (NRL) in Malaysia and refining the research and development of manufacturing processes for applications using Vytex NRL, such as latex foam, condoms, adhesives, medical devices, etc. Dr. Matthan is an internationally renowned latex and rubber expert. Dr. Matthan has been associated with the development of natural rubber and rubber based industries manufacturing in South Asia since the 1970s and introduced technically specified natural rubber into India. He has advised national and international companies and research bodies including the Government of India, the Malaysian Rubber Research and Development Board, Asian Development Bank, Industrial Development Bank of India, Revertex (Malaysia) as well as many private companies engaged in latex production and manufacturing. A founding Director of the Bangkok-based Asia Pacific Elastomer Science and Technology (APEST), he has played a key role in sustainability initiatives for natural rubber. He has also been associated with the development and commercial introduction of several eco-friendly natural rubber grades, including Vytex NRL. Dr. Matthan has been a Director of Vystar Corporation since March 12, 2015. Dr. Matthan has received numerous industry awards, including: the prestigious 2014 Institute of Materials, Minerals and Mining, U.K.’s Hancock Medal for his contributions to the development of the environmentally friendly sustainable growth of the global natural rubber industry and the 2006 KMPhilip Award from the All India Rubber Industries Association for significant contributions toward the development of the Indian Rubber Industry. Dr. Matthan has published over 50 scientific and technical papers on natural rubber and lattices and is an invited speaker at several international conferences including the International Latex Conference. v/r Sterling https://investorshub.advfn.com/boards/read_msg.aspx?message_id=146107541 Key Point #5**Significant VYST $31,319,398 Tax NOL Benefit VYST has $31,319,398 listed on their Balance Sheet as an Accumulated Deficit within their last Quarterly filing below: https://www.otcmarkets.com/filing/html?id=13070644&guid=kjy8UWUD04sjm3h To first understand what this is and the importance of what it means, I think it is important for one to understand that “Liabilities” and “Expenses”are two different things. “Liabilities” apply to the Balance Sheet and “Expenses” apply to the Income Statement. The $31,319,398 listed on theirBalance Sheet as an Accumulated Deficit is nowhere near as bad as I believe it is being perceived by some. An Accumulated Deficit is used as a Tax Shelter for tax write-offs. It’s a non-issue and basically a psychological paper entry because it will only affect the Balance Sheet and not the Income Statement for valuation purposes to derive an Earning Per Share (EPS). This will have no negative effect on the outcome for what the company’s EPS will be now or in the future, but instead, on the contrary. An Accumulated Deficit greatly enhances the company’s position as a huge acquisition/merger candidate. This is very attractive for a huge positive Revenue generating company with a significant amount of Gross & Net Income to merge into VYST. Therefore Rotmans Furniture, with its over $35 Million in Revenues and while having 48% to 52% Gross Profit Margin and a 19% Net Profit Margin is a great candidate for VYST. This is huge because the $31,319,398 is available to be used as a 2 year carry back and 20 year carry forward Tax Net Operating Loss (NOL)to reduce the taxable income for the company’s future tax years. That’s an average of $1,565,970 in the reduction of its taxable income per year over a 20 year time frame that’s derived by dividing such below considering VYST has an Outstanding Shares (OS) amount of 500,000,000 shares. If this number or any other variable changes in the future, then use the Substitution Property accordingly: $31,319,398 ÷ 20 Years Max Tax NOL = $1,565,970 Per Year Reduction For the purpose of what I believe is more logical and since getting to the NASDAQ is a primary goal, I believe VYST after acquiring/merging intoRotmans Furniture, will use the $31,319,398 Tax NOL to be carry forward to strengthen their Income Statement over the next four years since they are very profitable. This means that an average of $7,829,850 per year would exist for the reduction of its taxable income per year over a 4 year time frame derived by the logic below: $31,319,398 ÷ 4 Years Logical Tax NOL = $7,829,850 Per Year Reduction For what I am going to explain next, I will refer to the $7,829,850 that I explained above as Derivative Net Income for the purpose of deriving an understanding of what this $7,829,850 tax benefit would be worth over the next 4 years considering if VYST was to acquire/merge into a company generating significant Revenues and Net Income such as Rotmans Furniture which was indicated within their 10-Q filed with the SEC. This is basically like adding $7,829,850 back into a merging company’s Net Income that will be derived for any substantial amount of Net Incomethat would be generated. Merging into VYST would be better versus registering as a new entity or IPO-ing because you won’t have such huge ”tax shelter” otherwise as a huge tax benefit already existing here with VYST. Please, let me further explain. Considering the Outstanding Shares (OS) of 500,000,000 shares for VYST, we can derive what I will call a Derivative Earnings Per Share (EPS)to determine what the value of this tax benefit is worth to a company coming into VYST generating significant Net Income considering the formula below: Net Income ÷ Outstanding Shares (OS) = EPS $7,829,850 ÷ 500,000,000 shares = .0157 Derivative EPS The current Price to Earnings (PE) Ratio for the Furniture Industry within the link below is 17.41, but since the trailing PE Ratio is 36.53, I will use20 which I believe is conservative: http://pages.stern.nyu.edu/~adamodar/New_Home_Page/datafile/pedata.html So, conservatively speaking, this makes the Accumulated Deficit of $31,319,398 from being approximately worth $7,829,850 per year over the next 4 years to be worth .314 per share as derived below: .0157 Derivative EPS x 20 P/E Ratio = .314 Per Share of Added Value I am simply saying that if Rotmans Furniture merges into or is acquired by VYST, which was indicated to be doing such within their 10-Q filed with the SEC, since it is profitable with having Net Income, then the amount of value ”to be added” for worth from the NOL will be .314 per share as”added valuation” over the next 4 years to a the VYST EPS. This alone is absolutely huge! This means that the .67+ and the .26+ per share VYST valuations within the post below can be made to be .98+and the .57+ per share VYST valuations; https://investorshub.advfn.com/boards/read_msg.aspx?message_id=146050256 So, in closing, the $31,319,398 that you see on the Balance Sheet is actually an Accumulated Deficit during the development stages and is listed under the Liabilities and is strategically placed to not hurt the company as such is not in the form of any kind of notes to bring about any dilution. It was created Accumulated Deficits from the old management since the inception of the public entity and is being used by the new management as a Net Operating Loss carry forward for federal income tax purposes. Below are some good videos to listen and understand the logic regarding Net Operating Losses (NOL): http://www.investopedia.com/video/play/net-operating-loss-nol/?ad=dirN&qo=serpSearchTopBox&qsrc=1&o=40186 http://www.investopedia.com/terms/l/losscarryforward.asp http://www.investopedia.com/terms/n/netoperatingloss.asp Net Operating Losses (NOLs) on the 3 Financial Statements https://www.youtube.com/watch?v=p_53cPDNxCQ http://dlvr.it/Qwpq6j

[trendingnewsb]

10+ Times Writers Took Book Dedications To Another Level

Graduate Texts In Mathematics – An Introduction To Algebraic Topology By Joseph J. Rotman

source

Top-Tier Book Dedication

source

Relatable

Joan Rivers’ Dedication Page Of Her Last Book, Diary Of A Mad Diva

source

Skulduggery Pleasant – Mortal Coil By Derek Landy

source

No Way Back By Matthew Klein

source

I’ve Never Before Chosen A Book Based Simply On The Dedication

source

When You’re So Far In The Friendzone You Get A Book Dedication. Austenland By Shannon Hale

source

The Selection By Kiera Cass

source

Mortal Gods (The Goddess War) By Kendare Blake

source

The Invisible Hook: The Hidden Economics Of Pirates By Peter Leeson

source

City Of Golden Shadow (Otherland, Volume 1) By Tad William

source

Let’s Pretend This Never Happened: A Mostly True Memoir By Jenny Lawson

source

One Of The Most Important Parts Of Connor Franta’s New Book Is The Dedication

source

Opened Up My Finance Textbook And Found This Dedication

source

Finally Sitting Down To Enjoy The Utterly Beautiful, Funny, Captivating New Book From Moose Allain, Which Has The Most Wonderful Dedication

source

Chelsea Chelsea Bang Bang By Chelsea Handler

source

Product Details The Land Of Stories: Beyond The Kingdoms By Chris Colfer

source

A Well Written Dedication Can Tell You More About The Author Than Their Bio At The End

source

My Next Bedtime Reading. The Dedication Makes Me Chuckle

source

Omg The Dedication In My Lady Jane

source

More New Life Goal: Someday Writing A Book Dedication Half As Good As This One

source

I Love This Book Dedication

source

To Everyone Who Wonders If I’m Writing About Them

E.E. Cummings Self-Published his book With The Help Of His Mother And Dedicated It To The Fourteen Publishing Houses Who Turned The Collection Down

source

That Moment When You’re Already Amused And It’s Only The Dedication Page

source

Picked Up A Book By My Lecturer And I’m Pretty Sure The Dedication Is To His Dog

source

They Deserved It!

Hooked On Judd Apatow’s Book Since The Dedication Page

source

Nothing Can Possibly Go Wrong By Prudence Shen And Faith Erin Hicks

source

The End Games By T. Michael Martin

source

The House Of Hades By Rick Riordan

source

The Dedication Page In Dirk Gently’s Holistic Detective Agency

source

Found A Great Dedication In A Book I Got For Christmas

source

Best Book Dedication

source

Thicker Than Water, Melissa L Meyer

source

The Dedication Page To This Book Is Great

source

“Spindle” By E.K. Johnston

source

Skulduggery Pleasant: The End Of The World By Derek Landy

source

Skulduggery Pleasant – Death Bringer By Derek Landy

source

Yes. I Bought This Book Based On The Dedication Page

source

This Is A Book Dedication

source

from Viral News HQ http://ift.tt/2hjKukJ via Viral News HQ

#IFTTT #Viral News HQ

[vidmidnews]

Graduate Texts In Mathematics – An Introduction To Algebraic Topology By Joseph J. Rotman source When You’re So Far In The Friendzone You Get A Book Dedication. Austenland By Shannon Hale source No Way Back By Matthew Klein source Top-tie

#news

[sixpenceee]

Graduate Texts In Mathematics - An Introduction To Algebraic Topology By Joseph J. Rotman

#science

[otcsocialnetwork]

Key Point #4** $VYST Key Ownership Confirmed via Form 4s 

Key Point #4**VYST Key Ownership Confirmed via Form 4s After speaking to the company, I learned that Insiders own over 75% of the company. I was told that in the ten years since the Inside ownership has been owning their shares, there has been not one sell. I was told that this can be confirmed via the hundreds of Form 4s filed with the SEC as some of them are very prominent people of which are on the Board for the company. I counted over 280 ownership forms filed, but I won’t go through them all as I will try to only highlight a few key prominent VYST personnel and Board Members. Even though some might not be Board Members anymore, they still are shareholders and provide major input for their investment into VYST and still have a vested interest in their success: (Sort by the “100 Entries” tab) https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001308027&type=&dateb=&owner=only&start=100&count=100 Quote: Doug Craft CEO of and owns Medicraft, Inc. who is the largest supplier to Medtronic in the world. Medtronic is a $113.9 Billion company that trades on the NYSE at $84.00+ per share: https://finance.yahoo.com/quote/MDT/key-statistics?p=MDT https://www.medtronic.com/us-en/index.html http://www.medicraft.com/ Mitsy Y. Mangum Owns Lakeview Capital Partners LLC which an over $3 billion in assets under management and she is also a Managing Director: https://www.bloomberg.com/profiles/people/16697549-mitsy-y-mangum https://www.bloomberg.com/profiles/companies/1299368D:US-lakeview-capital-partners-llc This link shows that Lakeview Capital Partners has $2.6 Billion in Assets: https://money.usnews.com/financial-advisors/firm/lakeview-capital-partners-llc-165931 Michael Ianacone ** Previously the old VP of Xerox Global and has his own value company now. Quote: https://filexch.host/?q=Mike+ianacone+xerox+drivers Joseph C. Allegra ** Owns Lincoln Lee Investment, Zurich Investment (a hedge Fund), Diamond Investments I and II, Italian Air I and II. ** He owns the patent on the titanium surgical screw that many people use in many surgeries. ** On the Board Of Directors for MET-test: https://www.mymettest.com/ Quote: http://www.mettest.net/about_us.html Since inception in 2003, MET-TEST has been providing pulmonary function testing (PFT) and cardiopulmonary exercise testing (CPET) as a standard and centralized service to community based clinics. We have performed well over 65,000 tests and studies in the last 7 years and in the process have accumulated study results and expertise that we routinely share with partners. We work very closely with Dr. Wasserman at Harbor-UCLA, which is nationally recognized as the number one exercise physiology lab in the world. We currently provide services to 53 clinics in nine states as well as participating in Clinical Trials with a Pharma partner. Our expansion plans not only include additional sites in the United States but International as well. We are a privately held corporation headquartered in Atlanta, Georgia. Quote: http://www.mettest.net/board_of_diretors.html Quote: J C Allegra, MD Age 62 Atlanta Georgia Married ( Marilyn ) 3 children / BA from Temple University ( Chemistry ) 1970 / MD from Penn State University//Hershey Medical Center 1974 / Internship and Residency Internal Medicine 1974-1976 Hershey Medical Center / Fellowship Medical Oncology NIH/NCI Bethesda MD 1976-1978 /Senior Investigator NIH/NCI 1978-1980 /Military USPHS 1976-1980 Lt Cmdr / Professor and Chairman of Department of Medicine at University of Louisville 1982-1989 / Ended academic career in 1989 and moved to Atlanta Georgia to become President of T-2 Medical a physician centric Home Health Company Responsible for revenue growth between 1989 and 1993 from 50M to 300M and for listing T-2 on NYSE. Post T-2 functioned as President of OTI a Division of PhyMatrix which was a physician management company in Florida. Left PhyMatrix in 1997 to form NMCR a physician oriented education company and from 1997–2006 led the growth of NMCR to the largest oncology oriented education company in the USA prior to its purchase by Amerisource Bergen. Since 2006, I have functioned as the owner of Lincoln Lee Investments, LLC a family owned investment organization oriented to Health Care Investments Serve on numerous Public and Private Boardsand am the author of over 100 publications in peer reviewed medical publication. Dr. Keith D. Osborn ** Keith is a surgeon by trade, but has vast real estate holdings who is also a big investor with Joe Allegra, the other VYST Board Member. https://www.resurgens.com/physicians/keith-d-osborn-md Quote: https://www.bloomberg.com/research/stocks/people/person.asp?personId=183937861&privcapId=12739579 Mr. Keith D. Osborn, M.D., serves as Orthopedic Spine Surgeon at Resurgens Orthopaedics, Atlanta, GA. Mr. Osborn serves as a Member of Technical Advisory Board at Vystar Corporation. He has been Director of Vystar Corporation since May 18, 2016. He is a board-certified Orthopaedic Spine Surgeon with 30 years of experience after completing his Spine Fellowship at Harvard University. He received his medical degree from the University of Maryland School of Medicine and performed his residency at Harvard University and Johns Hopkins Hospital. Dr. Osborn currently specializes in Spinal Surgery at Resurgens Orthopaedics in Atlanta with a focus on adult spinal disorders and total disc arthroplasty. Paul R. Oristaglio Quote: https://www.bloomberg.com/research/stocks/people/person.asp?personId=571959708&privcapId=12739579 Mr. Paul R. Oristaglio, CPA has been a Director of Vystar Corp. since June 20, 2018. Mr. Oristaglio is the Chief Executive Officer and Founder of CFO2higher, which provides financial solutions to business owners and managers, which Mr. Oristaglio started in May 2018. Prior to his position with CFO2higher, Mr. Oristaglio served as President and Sole Proprietor of RIPRO, a financial and operational services company, and prior to that, MR. Oristaglio was CFO, COO, CIO and Co-Founder of MassPRO, Inc., a financial/operation resources company. Mr. Oristaglio is a licensed CPA. Mr. Oristaglio was chosen to serve as a director due to his business acumen and financial background. https://www.cfo2higher.com/ Steven Rotman Vystar Names Furniture Industry Leader Steve Rotman as CEO; Appoints 3 Board Members Quote: https://www.cnbc.com/2017/12/20/globe-newswire-vystar-names-furniture-industry-leader-steve-rotman-as-ceo-appoints-3-board-members.html Mr. Rotman brings extensive management experience to Vystar. He has been President and CEO of Rotmans, one of the oldest and largest furniture and carpet retailers in New England, for more than 40 years. … “I’m looking forward to working with the Vystar team and its partners in this new role to unleash Vystar’s sales and profitability potential,” stated Steve Rotman. “Vystar’s management, largest creditors, partners, NHS Holdings and major shareholders have worked together over the past six months to formulate a three-pronged strategic plan that would create a sustainable model to bring greater value to all Vystar shareholders. The three strategies are 1) revise Vystar’s business model to enhance revenues beyond Vytex as a pure commodity, 2) augment product offerings, profit margins, and revenues through acquisition, and 3) add depth to senior management.” Lam Ngoc Minh Quote: https://globenewswire.com/news-release/2017/06/01/1005429/0/en/Major-Latex-Foam-Producer-Lien-A-Partners-with-Vystar-CEO-Invests-in-Vystar.html VYST has formed a strategic partnership with Lien ‘A, pairing Vystar’s multi-patented, all-natural, virtually allergen free Vytex® latex with one of the top eco-friendly latex foam producers in Vietnam who provides natural rubber latex (NRL) products to 31 countries worldwide. Over the past year, Lien ‘A’s CEO Lam Ngoc Minh took significant equity positions in Vystar and NHS Holdings, LLC (NHS)… Minh joins a core group of Vystar investors who have invested $20 million in Vystar since inception to launch Vytex in multiple vertical markets and spur the latex and plastics industries to change to sustainably sourced, more durable and biodegradable materials. Dr. Bryan L. Stone Quote: https://www.bloomberg.com/research/stocks/people/person.asp?personId=547878243&privcapId=12739579 Dr. Bryan Lawrence Stone , M.D. serves as Interim CEO of Fluid Energy Conversion, Inc. Dr. Stone is the Chairman of Medicine at Desert Regional Medical Center in Palm Springs, Calif., and is the Medical Director at multiple DaVita Dialysis Centers. He is also an entrepreneur. He has advised Vystar over the past years relating to product development for the healthcare industry and brings to the board an understanding of the challenges of new product development for start-up companies. He has been Director of Vystar Corporation since December 20, 2017. William R. Doyle Quote: https://www.bloomberg.com/research/stocks/people/person.asp?personId=49551313&privcapId=12739579 Mr. William R. Doyle, also known as Bill, has been Product Development Consultant at Vystar Corporation since December 20, 2017. Mr. Doyle served as Chief Executive Officer of Vystar Corporation since March 2008 until December 20, 2017 and served as its President since December 2005 and served as its Chief Financial Officer since May 1, 2015. Mr. Doyle served as the Interim Chief Financial Officer of Vystar Corporation from July 29, 2014 to February 1, 2015 and served as its Chief Operating Officer since December 2005. Mr. Doyle served as Vice President of Marketing at Women’s Health for Matria Healthcare, Inc. He spearheaded the initial branding efforts at Matria as well as held responsibility for sales development, training, public relations and marketing. He has worked in many aspects of healthcare industry for over twenty years encompassing manufacturing, sales, marketing and advertising. In addition to Matria, he has experience with such companies as Isolyser Company, Inc., McGaw, Inc., Wyeth (Formerly, Lederle Laboratories), and in an advertising capacity for Novartis Ophthalmics. He served as Chairman of the Board at Vystar Corporation since March 2008 until December 20, 2017. He served as a Director of Vystar Corporation since 2005 until December 20, 2017. He serves as a Member of the Board of Directors of the Georgia Chapter of the March of Dimes. Mr. Doyle holds a Bachelor of Science in Biochemistry from Penn State University and Master of Business Administration from Pepperdine University. Ranjit K Mattha Quote: https://www.bloomberg.com/research/stocks/people/person.asp?personId=288343347&privcapId=12739579 Dr. Ranjit K. Matthan, Ph.D. serves as Director of R&D at Vystar Corporation. Dr. Matthan served as a Consultant to Vystar since 2008. Dr. Matthan has played a significant role in the manufacturing scale up of reduced-protein Vytex® natural rubber latex (NRL) in Malaysia and refining the research and development of manufacturing processes for applications using Vytex NRL, such as latex foam, condoms, adhesives, medical devices, etc. Dr. Matthan is an internationally renowned latex and rubber expert. Dr. Matthan has been associated with the development of natural rubber and rubber based industries manufacturing in South Asia since the 1970s and introduced technically specified natural rubber into India. He has advised national and international companies and research bodies including the Government of India, the Malaysian Rubber Research and Development Board, Asian Development Bank, Industrial Development Bank of India, Revertex (Malaysia) as well as many private companies engaged in latex production and manufacturing. A founding Director of the Bangkok-based Asia Pacific Elastomer Science and Technology (APEST), he has played a key role in sustainability initiatives for natural rubber. He has also been associated with the development and commercial introduction of several eco-friendly natural rubber grades, including Vytex NRL. Dr. Matthan has been a Director of Vystar Corporation since March 12, 2015. Dr. Matthan has received numerous industry awards, including: the prestigious 2014 Institute of Materials, Minerals and Mining, U.K.’s Hancock Medal for his contributions to the development of the environmentally friendly sustainable growth of the global natural rubber industry and the 2006 KMPhilip Award from the All India Rubber Industries Association for significant contributions toward the development of the Indian Rubber Industry. Dr. Matthan has published over 50 scientific and technical papers on natural rubber and lattices and is an invited speaker at several international conferences including the International Latex Conference. http://dlvr.it/QwkLVY